An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial
A. Saraf, R. Gurjar, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
An internet-delivered acceptance and commitment therapy program for anxious affect, depression, and wellbeing: A randomized, parallel, two-group, waitlist-controlled trial in a Middle Eastern sample of college students
Z. Vally, H. Shah, et al.
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial
A. H. Diacon, C. E. B. Iii, et al.
Multiple vaccine comparison in the same adults reveals vaccine-specific and age-related humoral response patterns: an open phase IV trial
M. V. D. Heiden, S. Shetty, et al.
Home-based transcranial direct current stimulation treatment for major depressive disorder: a fully remote phase 2 randomized sham-controlled trial
R. D. Woodham, S. Selvaraj, et al.
